Multiple breast cancer cells, MDA-MB-231, SUM149, MDA-MB-468, and SUM159 showed increased expression of pATG1, ATG5, ATG7 and BECN1 proteins in a temporal manner in response to HNK treatment (Fig. 1c, Supplementary Fig. 1). This evidence concerns the gene BECN1 and breast carcinoma.